Hereditary breast and ovarian cancer [25 genes]

The most frequent causes of hereditary breast and ovarian cancer are germinal variants in the BRCA1 and BRCA2 tumor suppressors. Likewise, other high-moderate penetrance genes exist, whose genetic effects lead to a predisposition to develop breast and ovarian cancer, such as TP53, PTEN, ATM, PALB2, and CDH1, among others.
Our experts recommend studying the predisposition for breast/ovarian syndrome through our general panel. Guided analysis in individuals who are of Ashkenazi Jew origin can be considered by starting with BRCA1 and BRCA2. Also, we offer the possibility of evaluating individually each of the genes in the panel.

Request study Informed consent
Steps to follow
Steps to follow
Click here to see the Guidelines for the collection and transport of biological samples

1) Download & fill out

Please cover as many fields as possible in both documents

2) Sample collection

See sample types in the guidelines

3) Pack the sample

Please pack the sample in a way to prevent leakage

4) Send the sample & the request

Please schedule the delivery for Monday–Friday: 8am – 5pm

5) Result: the report

Via: e-mail and/or through the customer portal

Ask for information
Solicita información de

Hereditary breast and ovarian cancer

"*" indicates required fields

Consentimiento*
This field is for validation purposes and should be left unchanged.
Technique: NGS capture panel

Turnaround time (TAT): 15 days

Ref. S-202211923

Hereditary breast and ovarian cancer: View panel
  • ATM
  • BARD1
  • BRCA1
  • BRCA2
  • BRIP1
  • CDH1
  • CHEK2
  • EPCAM
  • FANCC
  • FANCM
  • MLH1
  • MRE11A
  • MSH2
  • MSH6
  • NBN
  • NF1
  • PALB2
  • PMS2
  • PTEN
  • RAD50
  • RAD51B
  • RAD51C
  • RAD51D
  • STK11
  • TP53

Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.

Related panels
Hereditary breast and ovarian cancer [25 genes]